Blog Looking Drug Development Squarely in the Eye Aug 05, 2013 On Eureka we're always on the lookout for ways to use our existing processes in new ways that allow us to get the most information out of every experiment. A prime example of this can be found in optical coherence tomography (OCT). Non-Ocular Compounds May Call for Ocular Endpoints Jan 30, 2012 Should we include ocular endpoints in the preclinical development of products not targeted to the eye?
Looking Drug Development Squarely in the Eye Aug 05, 2013 On Eureka we're always on the lookout for ways to use our existing processes in new ways that allow us to get the most information out of every experiment. A prime example of this can be found in optical coherence tomography (OCT).
Non-Ocular Compounds May Call for Ocular Endpoints Jan 30, 2012 Should we include ocular endpoints in the preclinical development of products not targeted to the eye?
